The outcomes of salvage surgery for non-small cell lung cancer after immune checkpoint inhibitor or targeted therapy treatment. A multi-center international real-life study.
Guerrera F, Lococo F, Fournel L, Viggiano D, Mangiameli G, Mastromarino MG, Guggino G, Seitlinger J, Bertoglio P, Luzzi L, Ferrari PA, Filippini C, Alifano M, Margaritora S, Voltolini L, Voulaz E, Lucchi M, Romano FJ, Solli P, Najmeh S, Carta A, Ruffini E.
Guerrera F, et al.
Eur J Surg Oncol. 2025 Jun;51(6):109592. doi: 10.1016/j.ejso.2025.109592. Epub 2025 Jan 23.
Eur J Surg Oncol. 2025.
PMID: 40009921
Free article.